References
- Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480–93. https://linkinghub.elsevier.com/retrieve/pii/S1474442221004658
- Chiò A, Calvo A, Moglia C, Mazzini L, Mora G, Mutani R, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740–6.
- Chiò A, Moglia C, Canosa A, Manera U, D'Ovidio F, Vasta R, et al. ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94:e802–10–e810. http://www.neurology.org/lookup/doi/10.1212/WNL.0000000000008869
- Talman P, Duong T, Vucic S, Mathers S, Venkatesh S, Henderson R, et al. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort. BMJ Open. 2016;6:e012054.
- Hu MT, Ellis CM, Al-Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950–1. http://www.ncbi.nlm.nih.gov/pubmed/9854987
- Gamez J, Cervera C, Codina A. Flail arm syndrome or Vulpian-Bernhart’s form of amyotrophic lateral sclerosis [14]. J Neurol Neurosurg Psychiatry. 1999;67:258.
- Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology. 1999;53:1071–6. http://www.ncbi.nlm.nih.gov/pubmed/10496268
- Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009;72:1087–94.
- Schito P, Ceccardi G, Calvo A, Falzone YM, Moglia C, Lunetta C, et al. Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study. J Neurol Neurosurg Psychiatry. 2020;91:1001–3. http://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2020-323542
- Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, et al. Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis – data from a population-based registry. J Neurol Sci. 2014;345:164–7.
- Shefner JM, Al-Chalabi A, Baker MR, Cui L, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131:1975–8.
- De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuźma-Kozakiewicz M, et al. International survey of ALS experts about critical questions for assessing patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:505–10. https://www.tandfonline.com/doi/full/10.1080/21678421.2017.1349150
- Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma‐Kozakiewicz M, Pinto S, et al. Spreading in ALS: the relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol. 2020;7:1181–92. https://onlinelibrary.wiley.com/doi/abs/10.1002/acn3.51098
- Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169:13–21. https://www.sciencedirect.com/science/article/pii/S0022510X99002105?via%3Dihub
- Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, et al. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet. 2014;51:419–24. http://jmg.bmj.com/content/51/6/419.abstract
- Gromicho M, Coutinho AM, Pronto-Laborinho AC, Raposeiro R, Tavares J, Antunes D, et al. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE. J Neurol. 2020;267:3578–92.
- Hübers A, Hildebrandt V, Petri S, Kollewe K, Hermann A, Storch A, et al. Clinical features and differential diagnosis of flail arm syndrome. J Neurol. 2016;263:390–5.
- Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, et al. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86:1075–81. https://jnnp.bmj.com/lookup/doi/10.1136/jnnp-2015-310471
- Falcão de Campos C, Gromicho M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Oliveira Santos M, et al. Delayed diagnosis and diagnostic pathway of ALS patients in Portugal: where can we improve? Front Neurol 2021;12:1–7.
- Oliveira Santos M, Gromicho M, Pinto S, De carvalho M. Clinical characteristics in young-adult ALS–results from a Portuguese cohort study. Amyotroph Lateral Scler Front Degener. 2020; 21:620–3.
- Solski JA, Yang S, Nicholson GA, Luquin N, Williams KL, Fernando R, et al. A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:465–70.
- Riva N, Pozzi L, Russo T, Pipitone GB, Schito P, Domi T, et al. NEK1 variants in a cohort of Italian patients with amyotrophic lateral sclerosis. Front Neurosci 2022;16:1–8.
- Orrù S, Manolakos E, Orrù N, Kokotas H, Mascia V, Carcassi C, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172–8. https://onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2011.01668.x
- Vasta R, Chia R, Traynor BJ, Chiò A. Unraveling the complex interplay between genes, environment, and climate in ALS. eBioMedicine 2022;75:103795–12.
- Yoon B-N, Choi SH, Rha J-H, Kang S-Y, Lee K-W, Sung J-J. Comparison between flail arm syndrome and upper limb onset amyotrophic lateral sclerosis: clinical features and electromyographic findings. Exp Neurobiol. 2014;23:253–7.
- Couratier P, Truong CTri, Khalil M, Devière F, Vallat J-M. Clinical features of flail arm syndrome. Muscle Nerve. 2000;23:646–7. http://www.ncbi.nlm.nih.gov/pubmed/10716778
- Wei Q-Q, Chen Y, Chen X, Cao B, Ou RW, Zhang L, et al. Clinical and prognostic features of ALS/MND in different phenotypes–data from a hospital-based registry. Brain Res Bull. 2018;142:403–8.
- Chiò A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 2012;78:1085–9.
- De Carvalho M. Testing upper motor neuron function in amyotrophic lateral sclerosis: the most difficult task of neurophysiology. Brain. 2012;135:2581–2.